STOCK TITAN

Aramark US Financials

ARMK
Trailing 12 months to July 3, 2026
Revenue $19.8B +11.0% YoY
Net Income $382.9M +5.9% YoY
EPS (Diluted) $1.42 +5.2% YoY
Free Cash Flow $432.8M +54.2% YoY
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jul 3, 2026 Reported Currency USD FYE October

Aramark US (ARMK) reported $19.8B in revenue over the twelve months to Jul 3, 2026, up 11.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ARMK FY2025

Aramark combines low-margin service delivery with improving cash conversion, while leverage and near-balanced working capital remain central operating constraints.

In FY2025, operating cash flow was $921M versus net income of $326M, indicating cash generation materially exceeded reported earnings. After $489M of capital expenditures, free cash flow was $432M, so reinvestment absorbed nearly half of the operating cash produced.

Gross margin was 8.4% in FY2025, close to its FY2021 level of 9.0%. Operating margin reached 4.3% from 1.6%, making the improvement more consistent with efficiency below direct service delivery or operating scale than with gross-margin expansion.

The balance sheet became more leveraged in FY2025: debt-to-equity rose to 1.7x from 1.4x in FY2024, even as profitability improved. A current ratio of 1.0x means reported short-term assets approximately matched current liabilities, leaving limited working-capital cushion.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 41 / 100
Financial Health Score 41/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Aramark US's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
56

Aramark US has an operating margin of 4.3%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 56/100, indicating healthy but not exceptional operating efficiency. This is up from 4.1% the prior year.

Growth
58

Aramark US's revenue grew 6.4% year-over-year to $18.5B, a solid pace of expansion. This earns a growth score of 58/100.

Leverage
16

Aramark US has elevated debt relative to equity (D/E of 1.71), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 16/100, reflecting increased financial risk.

Liquidity
18

Aramark US's current ratio of 0.99 is below the typical benchmark, resulting in a score of 18/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
36

Aramark US has a free cash flow margin of 2.3%, earning a moderate score of 36/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
59

Aramark US's ROE of 10.4% shows moderate profitability relative to equity, earning a score of 59/100. This is up from 8.6% the prior year.

Altman Z-Score Grey Zone
2.54

Aramark US scores 2.54, placing it in the grey zone between 1.81 and 2.99. This signals moderate financial risk that warrants monitoring.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong
8/9

Aramark US passes 8 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
2.82x

For every $1 of reported earnings, Aramark US generates $2.82 in operating cash flow ($921.0M OCF vs $326.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
2.17x

Aramark US earns $2.17 in operating income for every $1 of interest expense ($791.8M vs $364.4M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$18.5B
YoY+6.4%
5Y CAGR+7.6%
10Y CAGR+2.6%

Aramark US generated $18.5B in revenue in fiscal year 2025. This represents an increase of 6.4% from the prior year.

EBITDA
$1.3B
YoY+11.0%
5Y CAGR+30.9%
10Y CAGR+1.1%

Aramark US's EBITDA was $1.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 11.0% from the prior year.

Net Income
$326.4M
YoY+24.3%
10Y CAGR+3.3%

Aramark US reported $326.4M in net income in fiscal year 2025. This represents an increase of 24.3% from the prior year.

EPS (Diluted)
$1.22
YoY+23.2%
10Y CAGR+2.4%

Aramark US earned $1.22 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$431.8M
YoY+44.4%
10Y CAGR+4.5%

Aramark US generated $431.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 44.4% from the prior year.

Cash & Debt
$639.1M
YoY-5.0%
5Y CAGR-23.9%
10Y CAGR+18.0%

Aramark US held $639.1M in cash against $5.4B in long-term debt as of fiscal year 2025.

Dividends Per Share
$0.42
YoY+10.5%
5Y CAGR-0.9%

Aramark US paid $0.42 per share in dividends in fiscal year 2025. This represents an increase of 10.5% from the prior year.

Shares Outstanding
263M
YoY-0.4%
5Y CAGR+0.8%
10Y CAGR+0.9%

Aramark US had 263M shares outstanding in fiscal year 2025. This represents a decrease of 0.4% from the prior year.

Margins & Returns

Gross Margin
8.4%
YoY+0.2pp
5Y CAGR+1.8pp
10Y CAGR-1.8pp

Aramark US's gross margin was 8.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.2 percentage points from the prior year.

Operating Margin
4.3%
YoY+0.2pp
5Y CAGR+6.3pp
10Y CAGR-0.1pp

Aramark US's operating margin was 4.3% in fiscal year 2025, reflecting core business profitability. This is up 0.2 percentage points from the prior year.

Net Margin
1.8%
YoY+0.3pp
5Y CAGR+5.4pp
10Y CAGR+0.1pp

Aramark US's net profit margin was 1.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.3 percentage points from the prior year.

Return on Equity
10.4%
YoY+1.7pp
5Y CAGR+27.2pp
10Y CAGR-2.2pp

Aramark US's ROE was 10.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.7 percentage points from the prior year.

Capital Allocation

Share Buybacks
$169.8M
YoY+1079.8%
5Y CAGR+91.8%
10Y CAGR+13.0%

Aramark US spent $169.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 1079.8% from the prior year.

Capital Expenditures
$489.2M
YoY+14.5%
5Y CAGR+3.2%
10Y CAGR-0.7%

Aramark US invested $489.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 14.5% from the prior year.

R&D Spending

Not reported for fiscal year 2025.

ARMK Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ARMK quarterly income statement
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Revenue$5.1B+3.1%$4.9B+1.6%$4.8B-4.3%$5.0B+9.1%$4.6B+8.1%$4.3B-6.0%$4.6B+3.1%$4.4B
Cost of Revenue$4.6B+3.3%$4.5B+1.5%$4.4B-4.7%$4.6B+8.8%$4.3B+8.6%$3.9B-5.6%$4.2B+3.3%$4.0B
Gross Profit$430.3M+0.9%$426.4M+2.5%$416.2M0.0%$416.0M+12.4%$370.1M+2.9%$359.6M-10.3%$400.9M+1.0%$397.0M
SG&A Expenses$78.6M+5.6%$74.5M+2.5%$72.7M-1.7%$73.9M+12.5%$65.7M-4.0%$68.4M-2.8%$70.4M+7.5%$65.5M
Operating Income$215.6M-1.9%$219.7M+1.0%$217.5M-0.1%$217.8M+19.3%$182.6M+4.8%$174.2M-19.8%$217.3M-0.7%$218.8M
Interest ExpenseN/AN/AN/AN/AN/AN/AN/A$106.8M
Income Tax$37.9M+7.1%$35.4M-9.6%$39.1M+85.5%$21.1M-12.9%$24.2M+7.7%$22.5M-37.1%$35.8M-4.2%$37.3M
Net Income$97.7M-4.2%$102.0M+6.0%$96.2M+10.4%$87.1M+21.4%$71.8M+16.1%$61.9M-41.4%$105.6M-13.7%$122.4M
EPS (Diluted)$0.36-5.3%$0.38+5.6%$0.36+12.5%$0.32+18.5%$0.27+17.4%$0.23-41.0%$0.39-15.2%$0.46

Not reported in any period shown, so not listed: R&D Expenses.

ARMK Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ARMK quarterly balance sheet
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Total Assets$14.0B+1.0%$13.8B+2.2%$13.5B+1.8%$13.3B+0.2%$13.3B-1.5%$13.5B+6.2%$12.7B+0.3%$12.7B
Current Assets$3.9B+2.9%$3.7B+3.1%$3.6B+3.1%$3.5B-0.2%$3.5B-8.1%$3.8B+16.5%$3.3B-3.3%$3.4B
Cash & Equivalents$499.4M+5.0%$475.7M+8.2%$439.6M-31.2%$639.1M+27.4%$501.5M-45.5%$920.5M+90.1%$484.1M-28.0%$672.5M
Inventory$433.6M-4.3%$453.3M+9.3%$414.6M-1.0%$418.8M+6.2%$394.2M-2.9%$405.9M+10.7%$366.7M-5.4%$387.6M
Goodwill$5.0B+0.3%$5.0B+1.8%$4.9B+0.4%$4.9B+0.5%$4.9B+0.9%$4.8B+2.0%$4.7B+0.8%$4.7B
Total Liabilities$10.6B+0.2%$10.6B+2.2%$10.3B+1.8%$10.2B-0.4%$10.2B-2.6%$10.5B+8.8%$9.6B-0.1%$9.6B
Current Liabilities$3.0B-2.9%$3.1B+8.2%$2.9B-19.5%$3.5B+29.5%$2.7B-14.0%$3.2B-9.0%$3.5B-17.0%$4.2B
Long-Term Debt$6.1B+0.6%$6.1B-2.5%$6.2B+15.6%$5.4B-14.1%$6.3B+2.4%$6.1B+22.7%$5.0B+15.6%$4.3B
Total Equity$3.4B+3.5%$3.3B+2.3%$3.2B+1.9%$3.1B+2.1%$3.1B+2.1%$3.0B-2.0%$3.1B+1.4%$3.0B
Retained Earnings$652.3M+11.3%$586.3M+13.7%$515.8M+13.8%$453.3M+15.1%$393.7M+12.7%$349.5M+10.8%$315.5M+31.6%$239.7M

Not reported in any period shown, so not listed: Accounts Receivable.

ARMK Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ARMK quarterly cash flow statement
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Operating Cash Flow$117.2M-70.7%$400.3M+151.2%-$782.2M-166.5%$1.2B+1433.1%$76.7M-70.0%$255.9M+143.6%-$587.2M-157.5%$1.0B
Capital Expenditures$112.4M+11.0%$101.3M-17.1%$122.2M-14.1%$142.2M+27.7%$111.4M-3.8%$115.8M-3.4%$119.9M-13.9%$139.3M
Free Cash Flow$4.8M-98.4%$299.0M+133.1%-$904.4M-187.5%$1.0B+3077.9%-$34.7M-124.8%$140.1M+119.8%-$707.0M-180.1%$882.3M
Investing Cash Flow-$119.3M+26.7%-$162.8M-5.9%-$153.7MN/A-$131.7M+47.7%-$251.6M-9.0%-$230.8MN/A
Financing Cash Flow$31.2M+115.3%-$203.2M-127.6%$735.7MN/A-$387.2M-191.3%$423.9M-34.0%$642.7MN/A
Dividends Paid$31.6M+0.3%$31.5M0.0%$31.5M+14.3%$27.6M+0.2%$27.5M-1.0%$27.8M-0.1%$27.9M+11.2%$25.0M
Share Buybacks$913K-96.4%$25.1M-39.3%$41.3M+39.1%$29.7M-3.9%$30.9M-61.7%$80.7M+182.4%$28.6M+98.5%$14.4M

ARMK Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ARMK quarterly financial ratios
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24
Gross Margin8.5%-0.2pp8.7%+0.1pp8.6%+0.4pp8.2%+0.2pp8.0%-0.4pp8.4%-0.4pp8.8%-0.2pp9.0%
Operating Margin4.3%-0.2pp4.5%0.0pp4.5%+0.2pp4.3%+0.4pp4.0%-0.1pp4.1%-0.7pp4.8%-0.2pp5.0%
Net Margin1.9%-0.1pp2.1%+0.1pp2.0%+0.3pp1.7%+0.2pp1.6%+0.1pp1.5%-0.9pp2.3%-0.5pp2.8%
Return on Equity2.9%-0.2pp3.1%+0.1pp3.0%+0.2pp2.8%+0.4pp2.3%+0.3pp2.1%-1.4pp3.4%-0.6pp4.0%
Return on Assets0.7%0.0pp0.7%0.0pp0.7%+0.1pp0.7%+0.1pp0.5%+0.1pp0.5%-0.4pp0.8%-0.1pp1.0%
Current Ratio1.28+0.1x1.21-0.1x1.27+0.3x0.99-0.3x1.29+0.1x1.21+0.3x0.94+0.1x0.81
Debt-to-Equity1.80-0.1x1.85-0.1x1.94+0.2x1.71-0.3x2.030.0x2.02+0.4x1.61+0.2x1.42
FCF Margin0.1%-6.0pp6.1%+24.8pp-18.7%-39.2pp20.5%+21.2pp-0.8%-4.0pp3.3%+18.8pp-15.5%-35.5pp20.0%

Note: The current ratio is below 1.0 (0.99), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

What is Aramark US's annual revenue?

Aramark US (ARMK) reported $18.5B in total revenue for fiscal year 2025. This represents a 6.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Aramark US's revenue growing?

Aramark US (ARMK) revenue grew by 6.4% year-over-year, from $17.4B to $18.5B in fiscal year 2025.

Is Aramark US profitable?

Yes, Aramark US (ARMK) reported a net income of $326.4M in fiscal year 2025, with a net profit margin of 1.8%.

Aramark US (ARMK) reported diluted earnings per share of $1.22 for fiscal year 2025. This represents a 23.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Aramark US (ARMK) had EBITDA of $1.3B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Aramark US (ARMK) had $639.1M in cash and equivalents against $5.4B in long-term debt.

Aramark US (ARMK) had a gross margin of 8.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Aramark US (ARMK) had an operating margin of 4.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Aramark US (ARMK) had a net profit margin of 1.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Aramark US (ARMK) paid $0.42 per share in dividends during fiscal year 2025.

Aramark US (ARMK) has a return on equity of 10.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Aramark US (ARMK) generated $431.8M in free cash flow during fiscal year 2025. This represents a 44.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Aramark US (ARMK) generated $921.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Aramark US (ARMK) had $13.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Aramark US (ARMK) invested $489.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Aramark US (ARMK) spent $169.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Aramark US (ARMK) had 263M shares outstanding as of fiscal year 2025.

Aramark US (ARMK) had a current ratio of 0.99 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Aramark US (ARMK) had a debt-to-equity ratio of 1.71 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Aramark US (ARMK) had a return on assets of 2.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Aramark US (ARMK) has an Altman Z-Score of 2.54, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Aramark US (ARMK) has a Piotroski F-Score of 8 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Aramark US (ARMK) has an earnings quality ratio of 2.82x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Aramark US (ARMK) has an interest coverage ratio of 2.17x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Aramark US (ARMK) scores 41 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top